Mark Kubik Email & Phone Number
@i-mabbiopharma.com
1 phone found area 540
LinkedIn matched
Who is Mark Kubik? Overview
A concise factual answer block for searchers comparing this professional profile.
Mark Kubik is listed as Head of Business Development - Oncology at Akari Therapeutics, Plc, based in Longmont, Colorado, United States. AeroLeads shows a work email signal at i-mabbiopharma.com, phone signal with area code 540, and a matched LinkedIn profile for Mark Kubik.
Mark Kubik previously worked as Business Development at Athira Pharma and Head of Business Development at Stealth Mode Biotech. Mark Kubik holds Mba, Finance from University Of Colorado Boulder - Leeds School Of Business.
Email format at Akari Therapeutics, Plc
This section adds company-level context without repeating Mark Kubik's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Kubik. Compare company email patterns before reaching out.
About Mark Kubik
Biopharmaceutical Business Development Leadership
Listed skills include Biotechnology, Biopharmaceuticals, Life Sciences, Drug Development, and 23 others.
Mark Kubik's current company
Company context helps verify the profile and gives searchers a useful next step.
Mark Kubik work experience
A career timeline built from the work history available for this profile.
Business Development
Current
Head Of Business Development
Svp, U.S. & E.U. Business Development
Svp, U.S. & E.U. Business Development
Chief Business Officer
Chief Business Officer (Cbo)
Chief Business Officer
Chief Business Officer (Cbo)
Chief Business Officer
Led the Invenra Business Development TeamDeveloped and Managed new business opportunitiesLed Alliance and Portfolio ManagementOversaw pipeline of immuno-oncology bispecific (B-Body(TM) and SNIPER(TM)) antibodiesOversaw Strategic Partnerships
Chief Business Officer
Driven to Cure Cancer !Building an innovative biopharmaceutical business around transformative technologies and products across all major therapeutic and diagnostic modalities:1) third generation aptamer technology;2) small molecule discovery; and3) monoclonal antibody (mAb) and empowered mAbs
Senior Vice President, Business Development
Vice President, Business Development
Invenra is a private company focused on antibody discovery using next generation technologies for mAb and empowered mAb therapeutics.As a senior member of the Executive Team, my role was to lead our Business Development function, including:Technology Out-Licensing / PartneringProduct Out-Licensing / PartneringAlliance ManagementProduct and Technology In-Licensing
Senior Director, Business Development
Technology Out-Licensing & PartneringProduct Out-Licensing & PartneringProduct & Technology In-Licensing & PartneringAlliance ManagementMergers & Acquisitions
Director, Business Development
Management - Head of Business DevelopmentProduct Out-Licensing / PartneringTechnology Out-LicensingProduct and Technology In-LicensingMergers & AcquisitionsAlliance Management
Senior Manager, Business Development
Product Out-Licensing / PartneringTechnology and Patent Out-LicensingMergers & Acquisitions
Business Development Manager
Target and Technology Out-Licensing / PartneringTarget and Technology In-Licensing / AcquisitionCollaboration Management
Business Development Associate
Market ForecastsCompetitive Landscape AnalysesComprehensive Financial Model BuildingDue Diligence Team LeaderCommercial and Strategic AnalysesEstablished Revenue Recognition Models w/ FinanceManaged Trade Shows and Conferences
Sales Support Scientist
Developed Marketing Plans for Bioinformatic SoftwareInitiated, Developed, and Managed Client ContactsMarket Research and Competitive AnalysesPublished Papers, Demonstrated Software Products WW
Technology Development Specialist
Financial Valuation, Competitive Intelligence and Intellectual Property AnalysesInitiated, Developed and Managed Partnering Contacts
Research Associate Iii
Performed SELEX (Systematic Evolution of Ligands by Exponential Enrichment) experiments to find aptamers; against therapeutically relevant target molecules
Mark Kubik education
Mba, Finance
Ba, Molecular, Cellular And Developmental Biology (Mcdb)
Executive Education, Negotiation And Influence Strategies
Leadership Development Program (Ldp), Leadership
Frequently asked questions about Mark Kubik
Quick answers generated from the profile data available on this page.
What company does Mark Kubik work for?
Mark Kubik works for Akari Therapeutics, Plc.
What is Mark Kubik's role at Akari Therapeutics, Plc?
Mark Kubik is listed as Head of Business Development - Oncology at Akari Therapeutics, Plc.
What is Mark Kubik's email address?
AeroLeads has found 1 work email signal at @i-mabbiopharma.com for Mark Kubik at Akari Therapeutics, Plc.
What is Mark Kubik's phone number?
AeroLeads has found 1 phone signal(s) with area code 540 for Mark Kubik at Akari Therapeutics, Plc.
Where is Mark Kubik based?
Mark Kubik is based in Longmont, Colorado, United States while working with Akari Therapeutics, Plc.
What companies has Mark Kubik worked for?
Mark Kubik has worked for Akari Therapeutics, Plc, Athira Pharma, Stealth Mode Biotech, I-Mab Biopharma, and Genor Biopharma Co., Ltd..
How can I contact Mark Kubik?
You can use AeroLeads to view verified contact signals for Mark Kubik at Akari Therapeutics, Plc, including work email, phone, and LinkedIn data when available.
What schools did Mark Kubik attend?
Mark Kubik holds Mba, Finance from University Of Colorado Boulder - Leeds School Of Business.
What skills is Mark Kubik known for?
Mark Kubik is listed with skills including Biotechnology, Biopharmaceuticals, Life Sciences, Drug Development, Pharmaceutical Industry, Lifesciences, Drug Discovery, and Technology Transfer.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial